An open letter signed by more than 50 industry executives blasts a “fundamentally, fatally flawed” report that urges greater ...

A group of 53 biotech leaders are expressing their support for mifepristone in a letter to the Food and Drug Administration, ...

FDA Commissioner Marty Makary’s pledge to reexamine the safety of medication abortion isn’t just pointless — it’s dangerous.

Three years after the Dobbs decision, the legal challenges continue for activists on both sides of the abortion debate.

A study reveals that chemical abortions cause more harm than reported, with 22 times higher adverse events than the FDA label ...

In the second phase of CATALYST, individuals who had abnormal cortisol suppression were offered the opportunity to take part in a randomized trial of mifepristone, a medication that reduces the ...

In patients with hypercortisolism and inadequately controlled type 2 diabetes, mifepristone lowered HbA1c levels by about 1.5 ...